Trademark: 88381334
Status Date
Monday, November 27, 2023
Filing Date
Thursday, April 11, 2019
Published for Opposition
Tuesday, February 11, 2020
Abandoned Date
Monday, November 27, 2023
41 Educational services, namely, development and dissemination of printed educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting classes, seminars, conferences, and workshops in the field of the use of prescription pharmaceutical products for medical disorders, in the field of cancer, patient care; educational and entertainment services, namely, providing a motivational and educational speaker featuring information regarding medical disorders; training services in the field of patient support services relating to treatment of medical disorders; providing on-line electronic newsletters delivered by email, and blogs in the medical, pharmaceutical and health fields; none of the foregoing relating to diagnostic products or diagnostics
9 Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; none of the foregoing for diagnostic use
5 Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders for use in oncology; pharmaceutical mineral supplements and preparations for use in oncology; none of the foregoing for diagnostic use
36 Providing healthcare administration, namely, providing insurance verification and prior authorization services for others; none of the foregoing relating to diagnostic products or diagnostics; none of the foregoing relating to diagnostic products or diagnostics
35 Online wholesale services by direct solicitation by salespersons directed to end-users featuring pharmaceuticals; referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products in the nature of medical referrals; business administration of prescription drug co-payment programs; business administration of patient reimbursement programs; referral services in the field of co-pay assistance programs in the nature of providing insurance agent referrals; providing an online commercial information directory in the field of patient support featuring information regarding healthcare providers, sites at which subcutaneous injections could be administered and retail pharmacies or specialty pharmacies where patients could obtain pharmaceutical preparations; none of the foregoing relating to diagnostic products or diagnostics
44 Patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; providing patient support services relating to cancer and cancer treatment in the nature of an Internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing a website featuring information in the medical and health fields; providing a website featuring information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing information in the medical field and information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing health information; providing patients with information in the medical field; providing health information, namely, providing data on the genetics and genetic sequencing of cancer tumors and cells; none of the foregoing relating to diagnostic products or diagnostics
10 Drug delivery devices in the nature of drug delivery systems; drug delivery systems; injection device for pharmaceutical preparations; injectors for medical purposes in the nature of medical fluid injectors; none of the foregoing for diagnostic use
42 Medical and pharmaceutical research services; pharmaceutical research and development; none of the foregoing relating to diagnostic products or diagnostics
Nov 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 27, 2023
Abandonment - No Use Statement Filed
Aug 9, 2023
Assignment Of Ownership Not Updated Automatically
May 5, 2023
Notice Of Approval Of Extension Request E-Mailed
May 4, 2023
Sou Extension 5 Granted
Apr 27, 2023
Sou Extension 5 Filed
May 3, 2023
Case Assigned To Intent To Use Paralegal
Apr 27, 2023
Sou Teas Extension Received
Oct 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2022
Sou Extension 4 Granted
Oct 27, 2022
Sou Extension 4 Filed
Oct 27, 2022
Sou Teas Extension Received
Apr 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2022
Sou Extension 3 Granted
Apr 26, 2022
Sou Extension 3 Filed
Apr 26, 2022
Sou Teas Extension Received
Oct 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2021
Sou Extension 2 Granted
Oct 26, 2021
Sou Extension 2 Filed
Oct 26, 2021
Sou Teas Extension Received
Apr 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2021
Sou Extension 1 Granted
Apr 27, 2021
Sou Extension 1 Filed
Apr 27, 2021
Sou Teas Extension Received
Oct 27, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 17, 2020
Changes/Corrections After Pub Approval Entered
Sep 16, 2020
Assigned To Petition Staff
Aug 20, 2020
Extension Of Time To Oppose Process - Terminated
Aug 10, 2020
Teas Post Publication Amendment Received
Mar 11, 2020
Extension Of Time To Oppose Received
Feb 11, 2020
Official Gazette Publication Confirmation E-Mailed
Feb 11, 2020
Published For Opposition
Jan 22, 2020
Notification Of Notice Of Publication E-Mailed
Jan 6, 2020
Approved For Pub - Principal Register
Dec 24, 2019
Teas/Email Correspondence Entered
Dec 23, 2019
Correspondence Received In Law Office
Dec 23, 2019
Teas Response To Office Action Received
Jun 24, 2019
Notification Of Non-Final Action E-Mailed
Jun 24, 2019
Non-Final Action E-Mailed
Jun 24, 2019
Non-Final Action Written
Jun 21, 2019
Assigned To Examiner
Apr 29, 2019
New Application Office Supplied Data Entered
Apr 15, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
